Ionis Pharmaceuticals Market Sentiment

Ionis Pharmaceuticals Inc

IONSNASDAQ

Trade with Public

$43.67

-1.61-3.56%

最終更新: Oct 12, 5:25 PM

$43.85

-1.43-3.17%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Ionis Pharmaceuticals Market Sentiment

Market sentiment signals for Ionis Pharmaceuticals (IONS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 17.9% short float

Options Flow▼ 1.56 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

27 analysts

Options Flow (P/C)

1.56

More puts — Bearish

430 calls · 672 puts

Avg Consensus PT

$86

+96.8%

Highest Price Target

$129

+194.2%

Leerink Partners

Lowest Price Target

$46

+4.9%

UBS

Short Interest

17.9%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 24, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+128.1%	$100 → $100	Maintained	Buy
Sep 22, 2026	JP Morgan	Jessica Fye—	+59.6%	$76 → $70	Maintained	Overweight
Sep 15, 2026	Guggenheim	Debjit Chattopadhyay—	+82.5%	$89 → $80	Maintained	Buy
Sep 9, 2026	Barclays	Eliana Merle—	+93.9%	$90 → $85	Maintained	Overweight
Sep 8, 2026	Morgan Stanley	Michael Ulz—	+137.2%	$110 → $104	Maintained	Overweight
Sep 8, 2026	Goldman Sachs	Salveen Richter—	+27.7%	$69 → $56	Maintained	Neutral
Sep 8, 2026	BMO Capital	David Lebowitz—	+23.2%	$61 → $54	Maintained	Market Perform
Sep 8, 2026	Canaccord Genuity	Gary Nachman—	+93.9%	$95 → $85	Maintained	Buy
Sep 8, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+128.1%	$115 → $100	Maintained	Buy
Sep 4, 2026	Needham	Joseph Stringer—	+96.1%	$86 → $86	Maintained	Buy
Sep 4, 2026	BMO Capital	David Lebowitz—	+39.1%	$60 → $61	Maintained	Market Perform
Sep 4, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+162.3%	$115 → $115	Maintained	Buy
Aug 31, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+162.3%	$115 → $115	Maintained	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+36.8%	$60	Initiate	Outperform→Market Perform
Aug 3, 2026	JP Morgan	Jessica Fye—	+73.3%	$72 → $76	Maintained	Overweight
Jul 30, 2026	Wells Fargo	Yanan Zhu—	+116.7%	$100 → $95	Maintained	Overweight
Jul 30, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+162.3%	$125 → $115	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+103.0%	$106 → $89	Maintained	Buy
Jul 16, 2026	Wolfe Research	Andy Chen—	—	—	Downgrade	Outperform→Peer Perform
Jul 13, 2026	RBC Capital	Luca Issi—	+93.9%	$100 → $85	Maintained	Outperform
Jul 10, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+185.1%	$130 → $125	Maintained	Buy
Jul 10, 2026	Morgan Stanley	Michael Ulz—	+150.9%	$130 → $110	Maintained	Overweight
Jul 10, 2026	Barclays	Eliana Merle—	+105.3%	$115 → $90	Maintained	Overweight
Jul 10, 2026	Canaccord Genuity	Gary Nachman—	+116.7%	$110 → $95	Maintained	Buy
Jul 10, 2026	Citigroup	Eric Joseph—	+128.1%	$115 → $100	Maintained	Buy